High-purity Eptaplatin API — GMP Certified
Eptaplatin is a third-generation platinum-based antineoplastic agent with activity against various solid tumours, including cisplatin-resistant cancers. Mediocon Inc manufactures Eptaplatin API to IP/BP/EP/USP standards in its GMP-certified facility in Aurangabad, Maharashtra, India.
Our Eptaplatin API is supplied to oncology pharmaceutical manufacturers and research institutions globally with complete quality documentation, supporting the development of injectable cancer treatment formulations.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Eptaplatin (CAS 131262-79-4) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Eptaplatin is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance